1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one

C113H123F5N26O14 — CID 157157115

IUPAC1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one
SMILESCC(F)Oc1ccc(CC#N)cc1Cn1c2cc(-c3cnc(N4CCN(C(=O)CO)[C@H](C)C4)nc3)ccc2c(=O)n1C.CCC(c1cccc(C)c1)n1c2cc(-c3cnc(N4CCN(C(=O)CO)[C@H](C)C4)nc3)ccc2c(=O)n1C.C[C@@H]1CN(c2ncc(-c3ccc4c(=O)n(C(F)F)n(Cc5ccccc5OC(F)F)c4c3)cn2)CCN1C(=O)CO.Cc1cccc(C(C)n2c3cc(-c4cnc(N5CCN(C(=O)CO)[C@H](C)C5)nc4)ccc3c(=O)n2C)n1
InChIInChI=1S/C30H32FN7O4.C29H34N6O3.C27H26F4N6O4.C27H31N7O3/c1-19-16-36(10-11-37(19)28(40)18-39)30-33-14-24(15-34-30)22-5-6-25-26(13-22)38(35(3)29(25)41)17-23-12-21(8-9-32)4-7-27(23)42-20(2)31;1-5-25(22-8-6-7-19(2)13-22)35-26-14-21(9-10-24(26)28(38)32(35)4)23-15-30-29(31-16-23)33-11-12-34(20(3)17-33)27(37)18-36;1-16-13-34(8-9-35(16)23(39)15-38)27-32-11-19(12-33-27)17-6-7-20-21(10-17)36(37(24(20)40)25(28)29)14-18-4-2-3-5-22(18)41-26(30)31;1-17-6-5-7-23(30-17)19(3)34-24-12-20(8-9-22(24)26(37)31(34)4)21-13-28-27(29-14-21)32-10-11-33(18(2)15-32)25(36)16-35/h4-7,12-15,19-20,39H,8,10-11,16-18H2,1-3H3;6-10,13-16,20,25,36H,5,11-12,17-18H2,1-4H3;2-7,10-12,16,25-26,38H,8-9,13-15H2,1H3;5-9,12-14,18-19,35H,10-11,15-16H2,1-4H3/t19-,20?;20-,25?;16-;18-,19?/m1111/s1
InChIKeyALYCGOZNSBAUIX-NORAKORJSA-N
MW2164.38 g/mol
LogP11.24
Rot. Bonds27

About 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one

1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one (PubChem CID 157157115) has the molecular formula C113H123F5N26O14 and a molecular weight of 2164.38 g/mol. Its IUPAC name is 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one.

Molecular Properties

Compound Name1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one
PubChem CID157157115
Molecular FormulaC113H123F5N26O14
Molecular Weight2164.38 g/mol
Exact Mass2162.96
IUPAC Name1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one
SMILESCC(F)Oc1ccc(CC#N)cc1Cn1c2cc(-c3cnc(N4CCN(C(=O)CO)[C@H](C)C4)nc3)ccc2c(=O)n1C.CCC(c1cccc(C)c1)n1c2cc(-c3cnc(N4CCN(C(=O)CO)[C@H](C)C4)nc3)ccc2c(=O)n1C.C[C@@H]1CN(c2ncc(-c3ccc4c(=O)n(C(F)F)n(Cc5ccccc5OC(F)F)c4c3)cn2)CCN1C(=O)CO.Cc1cccc(C(C)n2c3cc(-c4cnc(N5CCN(C(=O)CO)[C@H](C)C5)nc4)ccc3c(=O)n2C)n1
InChIInChI=1S/C30H32FN7O4.C29H34N6O3.C27H26F4N6O4.C27H31N7O3/c1-19-16-36(10-11-37(19)28(40)18-39)30-33-14-24(15-34-30)22-5-6-25-26(13-22)38(35(3)29(25)41)17-23-12-21(8-9-32)4-7-27(23)42-20(2)31;1-5-25(22-8-6-7-19(2)13-22)35-26-14-21(9-10-24(26)28(38)32(35)4)23-15-30-29(31-16-23)33-11-12-34(20(3)17-33)27(37)18-36;1-16-13-34(8-9-35(16)23(39)15-38)27-32-11-19(12-33-27)17-6-7-20-21(10-17)36(37(24(20)40)25(28)29)14-18-4-2-3-5-22(18)41-26(30)31;1-17-6-5-7-23(30-17)19(3)34-24-12-20(8-9-22(24)26(37)31(34)4)21-13-28-27(29-14-21)32-10-11-33(18(2)15-32)25(36)16-35/h4-7,12-15,19-20,39H,8,10-11,16-18H2,1-3H3;6-10,13-16,20,25,36H,5,11-12,17-18H2,1-4H3;2-7,10-12,16,25-26,38H,8-9,13-15H2,1H3;5-9,12-14,18-19,35H,10-11,15-16H2,1-4H3/t19-,20?;20-,25?;16-;18-,19?/m1111/s1
InChIKeyALYCGOZNSBAUIX-NORAKORJSA-N
XLogP11.24
TPSA441.10 Ų
H-Bond Donors4
H-Bond Acceptors36
Rotatable Bonds27
Heavy Atoms158
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002164.38
LogP ≤ 511.24
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1036

Analyze 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-[[2-(difluoromethoxy)-5-methylphenyl]methyl]-6-[2-[(3S)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one
CID 122620266
1-[[2-(Difluoromethoxy)-5-methylphenyl]methyl]-6-[2-[4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one
CID 122620267
2-[4-(difluoromethoxy)-3-[[6-[2-[(2R)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile
CID 122620692
2-[4-(Difluoromethoxy)-3-[[6-[2-[4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile
CID 122620693
1-[[2-(difluoromethoxy)-5-methylphenyl]methyl]-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-(trideuteriomethyl)indazol-3-one
CID 122620708
1-[[2-(Difluoromethoxy)-5-methylphenyl]methyl]-6-[2-[4-(2-hydroxyacetyl)piperazin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one
CID 122620717
1-[[2-(difluoromethoxy)-5-methylphenyl]methyl]-6-[2-[(2R)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one
CID 122620810
1-[[2-(Difluoromethoxy)-5-methylphenyl]methyl]-6-[2-[4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one
CID 122620813
1-[[2-(difluoromethoxy)phenyl]methyl]-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one
CID 122620828
1-[[2-(Difluoromethoxy)phenyl]methyl]-6-[2-[4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one
CID 122620830
1-[[2-(difluoromethoxy)-5-methylphenyl]methyl]-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one
CID 122620886
1-[[2-(difluoromethoxy)phenyl]methyl]-6-[2-[(2S)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one
CID 122620888

Frequently Asked Questions

What is the IUPAC name of 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one?
The IUPAC name of 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one (CID 157157115) is 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one.
What is the SMILES notation for 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one?
The canonical SMILES for 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one is CC(F)Oc1ccc(CC#N)cc1Cn1c2cc(-c3cnc(N4CCN(C(=O)CO)[C@H](C)C4)nc3)ccc2c(=O)n1C.CCC(c1cccc(C)c1)n1c2cc(-c3cnc(N4CCN(C(=O)CO)[C@H](C)C4)nc3)ccc2c(=O)n1C.C[C@@H]1CN(c2ncc(-c3ccc4c(=O)n(C(F)F)n(Cc5ccccc5OC(F)F)c4c3)cn2)CCN1C(=O)CO.Cc1cccc(C(C)n2c3cc(-c4cnc(N5CCN(C(=O)CO)[C@H](C)C5)nc4)ccc3c(=O)n2C)n1.
What is the InChIKey of 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one?
The InChIKey is ALYCGOZNSBAUIX-NORAKORJSA-N. The full InChI is InChI=1S/C30H32FN7O4.C29H34N6O3.C27H26F4N6O4.C27H31N7O3/c1-19-16-36(10-11-37(19)28(40)18-39)30-33-14-24(15-34-30)22-5-6-25-26(13-22)38(35(3)29(25)41)17-23-12-21(8-9-32)4-7-27(23)42-20(2)31;1-5-25(22-8-6-7-19(2)13-22)35-26-14-21(9-10-24(26)28(38)32(35)4)23-15-30-29(31-16-23)33-11-12-34(20(3)17-33)27(37)18-36;1-16-13-34(8-9-35(16)23(39)15-38)27-32-11-19(12-33-27)17-6-7-20-21(10-17)36(37(24(20)40)25(28)29)14-18-4-2-3-5-22(18)41-26(30)31;1-17-6-5-7-23(30-17)19(3)34-24-12-20(8-9-22(24)26(37)31(34)4)21-13-28-27(29-14-21)32-10-11-33(18(2)15-32)25(36)16-35/h4-7,12-15,19-20,39H,8,10-11,16-18H2,1-3H3;6-10,13-16,20,25,36H,5,11-12,17-18H2,1-4H3;2-7,10-12,16,25-26,38H,8-9,13-15H2,1H3;5-9,12-14,18-19,35H,10-11,15-16H2,1-4H3/t19-,20?;20-,25?;16-;18-,19?/m1111/s1.
What are the key properties of 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one?
1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one has a molecular weight of 2164.38 g/mol, XLogP of 11.24, 27 rotatable bonds, 4 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[[2-(difluoromethoxy)phenyl]methyl]-2-(difluoromethyl)-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]indazol-3-one;2-[4-(1-fluoroethoxy)-3-[[6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-3-oxoindazol-1-yl]methyl]phenyl]acetonitrile;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(3-methylphenyl)propyl]indazol-3-one;6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl]-2-methyl-1-[1-(6-methyl-2-pyridinyl)ethyl]indazol-3-one is sourced from PubChem (CID 157157115), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).